IL10 and neoplasm: Additionally, AS-IV downregulated anti-inflammatory cytokines such as TGF-β, IL-10, and VEGF-A while upregulating pro-inflammatory cytokines including IFN-γ, IL-12, and TNF-α, thereby fostering a more immunologically active tumor milieu (Liu et al., 2020).